We subsequently demonstrated that UCN1 reduced endometrial cancer migration via CRFR2, as suppression of migration was completely eliminated by the addition of the CRFR2 antagonist whereas the addition of the CRFR1 antagonist did not reverse UCN1‐induced suppression of migration. Here, CRHR2 is linked to endometrial cancer.